FdaApplication
NDA 020261
Identifiers
- fda_app_no: NDA020261
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
| approval_date | 1993-12-31 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LESCOL | FLUVASTATIN SODIUM | EQ 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
| LESCOL | FLUVASTATIN SODIUM | EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
2 products